King Pharmaceuticals KG International — Year 5
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's international — year 5.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's international — year 5?
- King Pharmaceuticals (KG) reported international — year 5 of -0.8% in Q4 2025.
- What does international — year 5 mean?
- Reflects the financial performance and operational results of the International insurance product line during the fifth year of the reporting cycle. This metric tracks the evolution of underwriting profitability and market penetration in international territories. It is used to assess the maturity and stability of the segment over a mid-term horizon.